{"id":"placebo-for-inhalation","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL521875","moleculeType":"Small molecule","molecularWeight":"460.53"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebos are inert substances used in randomized controlled trials to establish the true efficacy of an active drug by comparison. An inhalation placebo mimics the delivery route and administration procedure of an active inhaled therapy without providing any pharmacological effect, allowing researchers to distinguish genuine drug effects from placebo response and natural disease progression.","oneSentence":"A placebo inhalation formulation that contains no active pharmaceutical ingredient and serves as a control comparator in clinical trials.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:00:56.734Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05528718","phase":"","title":"SMILE Trial - Imaging Sub-Study","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2023-03-07","conditions":"Major Depressive Disorder","enrollment":11},{"nctId":"NCT06703073","phase":"PHASE2","title":"JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)","status":"RECRUITING","sponsor":"PPD Development, LP","startDate":"2025-06-10","conditions":"Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)","enrollment":600},{"nctId":"NCT06701656","phase":"PHASE2","title":"JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab","status":"RECRUITING","sponsor":"PPD Development, LP","startDate":"2025-10-28","conditions":"Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)","enrollment":200},{"nctId":"NCT06701682","phase":"PHASE2","title":"JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab","status":"RECRUITING","sponsor":"PPD Development, LP","startDate":"2025-06-21","conditions":"Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)","enrollment":200},{"nctId":"NCT07493434","phase":"NA","title":"Evaluation of Pain Thresholds in Migraine Patients After Inhalation of Essential Oils: a Randomized Clinical Trial","status":"ENROLLING_BY_INVITATION","sponsor":"University of Sao Paulo","startDate":"2025-03-13","conditions":"Migraine","enrollment":200},{"nctId":"NCT06701669","phase":"PHASE2","title":"JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart","status":"RECRUITING","sponsor":"PPD Development, LP","startDate":"2025-06-10","conditions":"Acute Respiratory Distress Syndrome (ARDS), ARDS, ARDS (Acute Respiratory Distress Syndrome)","enrollment":200},{"nctId":"NCT06676319","phase":"PHASE2","title":"Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2024-11-07","conditions":"Asthma","enrollment":1147},{"nctId":"NCT05217498","phase":"PHASE1, PHASE2","title":"Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury","status":"NOT_YET_RECRUITING","sponsor":"Randy Trumbower, PT, PhD","startDate":"2027-09-01","conditions":"Spinal Cord Injuries, Myelopathy","enrollment":40},{"nctId":"NCT07481981","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)","status":"NOT_YET_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2026-04-17","conditions":"Pulmonary Arterial Hypertension","enrollment":344},{"nctId":"NCT07181382","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"SUSPENDED","sponsor":"GB002, Inc.","startDate":"2026-02","conditions":"Pulmonary Hypertension Associated With Interstitial Lung Disease","enrollment":480},{"nctId":"NCT06750289","phase":"PHASE3","title":"Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-03-28","conditions":"Eosinophilic Asthma","enrollment":400},{"nctId":"NCT01577082","phase":"PHASE3","title":"Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2012-04-20","conditions":"Asthma","enrollment":542},{"nctId":"NCT07480668","phase":"NA","title":"Aromatherapy for Mental Health Promotion in IVF Patients","status":"RECRUITING","sponsor":"Federal University of Minas Gerais","startDate":"2026-03","conditions":"Anxiety, Stress, Depression Disorder","enrollment":120},{"nctId":"NCT05934526","phase":"PHASE3","title":"Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)","status":"COMPLETED","sponsor":"GB002, Inc.","startDate":"2023-12-28","conditions":"Pulmonary Arterial Hypertension","enrollment":390},{"nctId":"NCT06329401","phase":"PHASE2","title":"A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Avalyn Pharma Inc.","startDate":"2024-04-03","conditions":"Progressive Pulmonary Fibrosis","enrollment":375},{"nctId":"NCT07317401","phase":"NA","title":"Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) to Improve Fatigue, Pain, and Quality of Life by Targeting Mitochondrial Dysfunction and Autonomic Nervous System Impairment","status":"NOT_YET_RECRUITING","sponsor":"University of Aarhus","startDate":"2026-06-01","conditions":"Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)","enrollment":104},{"nctId":"NCT06962852","phase":"PHASE1, PHASE2","title":"A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-05-20","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT05427630","phase":"PHASE2","title":"Dose-Ranging Trial of Inhaled Cannabis for Acute Migraine Treatment","status":"SUSPENDED","sponsor":"University of California, San Diego","startDate":"2023-02-15","conditions":"Migraine, Cannabis, THC","enrollment":20},{"nctId":"NCT05851443","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma","status":"RECRUITING","sponsor":"Incyte Corporation","startDate":"2023-07-11","conditions":"Moderate to Severe Asthma","enrollment":240},{"nctId":"NCT07037511","phase":"NA","title":"Effects of Salbutamol in Athletes and Implications for Screening and Sports","status":"RECRUITING","sponsor":"University of British Columbia","startDate":"2025-10-30","conditions":"Asthma, Healthy, Effect of Drug","enrollment":64},{"nctId":"NCT03953300","phase":"PHASE4","title":"Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-10-08","conditions":"Asthma","enrollment":75},{"nctId":"NCT07463339","phase":"PHASE2","title":"Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-05-01","conditions":"Critical Illness, Mechanical Ventilation","enrollment":70},{"nctId":"NCT07252908","phase":"PHASE2","title":"A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation Powder","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2025-12-22","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":195},{"nctId":"NCT02836899","phase":"PHASE3","title":"Effect of Nitric Oxide in Cardiac Surgery Patients With Endothelial Dysfunction.","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-02-08","conditions":"Acute Kidney Injury","enrollment":250},{"nctId":"NCT03822637","phase":"PHASE4","title":"The Effect of NAC on Lung Function and CT Mucus Score","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-02-20","conditions":"Asthma","enrollment":4},{"nctId":"NCT06166056","phase":"PHASE1, PHASE2","title":"A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Doses in Subjects With Bronchiectasis","status":"RECRUITING","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2023-11-29","conditions":"Bronchiectasis","enrollment":45},{"nctId":"NCT04458324","phase":"PHASE2","title":"Hybrid Functional Electrical Stimulation Exercise to Prevent Cardiopulmonary Declines in High-level Spinal Cord Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Spaulding Rehabilitation Hospital","startDate":"2020-12-22","conditions":"Spinal Cord Injuries","enrollment":70},{"nctId":"NCT06969573","phase":"PHASE2","title":"Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-06-05","conditions":"COPD (Chronic Obstructive Pulmonary Disease)","enrollment":20},{"nctId":"NCT07450482","phase":"PHASE2","title":"Safety and Efficacy of JKN2304 Inhalation Solution in Patients With Moderate to Severe COPD","status":"COMPLETED","sponsor":"Joincare Pharmaceutical Group Industry Co., Ltd","startDate":"2025-07-22","conditions":"COPD (Chronic Obstructive Pulmonary Disease), COPD","enrollment":42},{"nctId":"NCT05710887","phase":"PHASE2","title":"N2O for Acute Suicidality and Depression in the ED","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2026-02-27","conditions":"Suicidal Ideation, Major Depressive Disorder, Treatment Resistant Depression","enrollment":""},{"nctId":"NCT07179380","phase":"PHASE3","title":"Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"RECRUITING","sponsor":"Insmed Incorporated","startDate":"2026-01-07","conditions":"Pulmonary Hypertension, Interstitial Lung Disease","enrollment":344},{"nctId":"NCT07428083","phase":"NA","title":"Effect of Kinesio Taping Combined With Schroth Therapy in Young Adults With Idiopathic Scoliosis","status":"NOT_YET_RECRUITING","sponsor":"Fatih Sultan Mehmet Training and Research Hospital","startDate":"2026-02-01","conditions":"Scoliosis Idiopathic, Kinesio Taping","enrollment":51},{"nctId":"NCT06529419","phase":"PHASE2","title":"A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2024-08-30","conditions":"Asthma","enrollment":537},{"nctId":"NCT07439419","phase":"PHASE1","title":"DBM-1152A Inhalation Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"Joincare Pharmaceutical Group Industry Co., Ltd","startDate":"2024-08-18","conditions":"Healthy","enrollment":20},{"nctId":"NCT07116915","phase":"PHASE1","title":"A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder for Inhalation and Inhalation Suspension Administered in Healthy Subjects and Multiple Doses in Patients With COPD.","status":"RECRUITING","sponsor":"Guangdong Hengrui Pharmaceutical Co., Ltd","startDate":"2025-08-11","conditions":"COPD","enrollment":160},{"nctId":"NCT05649722","phase":"PHASE2, PHASE3","title":"An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2023-05-11","conditions":"Pulmonary Hypertension, Interstitial Lung Disease","enrollment":31},{"nctId":"NCT05649748","phase":"PHASE2, PHASE3","title":"An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insmed Incorporated","startDate":"2023-03-07","conditions":"Pulmonary Arterial Hypertension","enrollment":91},{"nctId":"NCT07434895","phase":"EARLY_PHASE1","title":"Repeated CBD Administration and Cannabis Outcomes","status":"NOT_YET_RECRUITING","sponsor":"Hannah Harris","startDate":"2026-03","conditions":"Cannabis, Abuse Liability, Experimental Pain in Healthy Human Participants","enrollment":23},{"nctId":"NCT05451264","phase":"NA","title":"Study of the Effect of Hydrocortisone Administered for the Prevention of Pulmonary Bronchodysplasia (PREMILOC Trial) on the Determinants of Systemic Blood Pressure in Children (PREMILOCAP)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-01-23","conditions":"Infant, Premature, Diseases","enrollment":52},{"nctId":"NCT06452095","phase":"NA","title":"Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-01","conditions":"Long COVID, Post Acute Sequelae of COVID-19, Post-COVID-19 Condition","enrollment":120},{"nctId":"NCT05222529","phase":"PHASE2","title":"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-08-29","conditions":"Asthma","enrollment":42},{"nctId":"NCT07423273","phase":"NA","title":"Hyperbaric Oxygen Therapy for Persistent Post Stroke Depression","status":"RECRUITING","sponsor":"Assaf-Harofeh Medical Center","startDate":"2023-11-08","conditions":"Post Stroke Depression","enrollment":142},{"nctId":"NCT06635850","phase":"PHASE2","title":"A Study of Mosliciguat in PH-ILD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pulmovant, Inc.","startDate":"2024-10-29","conditions":"Pulmonary Hypertension, Interstitial Lung Disease, Lung Diseases","enrollment":135},{"nctId":"NCT07419542","phase":"NA","title":"Effect of High Power Laser Acupuncture on Post Menopausal Hot Flashes","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-02-20","conditions":"Hot Flashes","enrollment":60},{"nctId":"NCT06515002","phase":"PHASE1, PHASE2","title":"A Study to Test How Well BI 3720931 is Tolerated and Whether it Improves Lung Function in People With Cystic Fibrosis (Lenticlair™ 1)","status":"TERMINATED","sponsor":"Boehringer Ingelheim","startDate":"2024-11-04","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT05888350","phase":"NA","title":"Biomarkers for Predicting the Response to Inhaled Corticosteroid in Patients With Chronic Cough.","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Guangzhou Medical University","startDate":"2023-04-01","conditions":"Cough","enrollment":502},{"nctId":"NCT07301710","phase":"PHASE1, PHASE2","title":"Low-Tech Treatments for Obstructive Sleep Apnea","status":"RECRUITING","sponsor":"Uniformed Services University of the Health Sciences","startDate":"2026-01-29","conditions":"Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)","enrollment":60},{"nctId":"NCT07413718","phase":"NA","title":"Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis","status":"RECRUITING","sponsor":"University Ramon Llull","startDate":"2025-09-01","conditions":"Amyotrophic Lateral Slerosis","enrollment":44},{"nctId":"NCT07415746","phase":"NA","title":"Functional Assessment and Pulmonary Rehabilitation: Challenges and Perspectives for Comprehensive Care","status":"NOT_YET_RECRUITING","sponsor":"Universidade do Estado do Pará","startDate":"2026-03","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":46},{"nctId":"NCT07295054","phase":"PHASE4","title":"3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion","status":"NOT_YET_RECRUITING","sponsor":"Women's College Hospital","startDate":"2026-03","conditions":"IUD","enrollment":110},{"nctId":"NCT06746064","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 Exposure","status":"COMPLETED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2025-01-13","conditions":"Pulmonary Fibrosis","enrollment":155},{"nctId":"NCT04708782","phase":"PHASE3","title":"Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"United Therapeutics","startDate":"2021-06-01","conditions":"Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease","enrollment":598},{"nctId":"NCT03375047","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-05-10","conditions":"Cystic Fibrosis","enrollment":42},{"nctId":"NCT06545500","phase":"PHASE2","title":"A Phase IIb Study of Glycopyrrolate Inhalation Solution Over 1 Week in Subjects With COPD","status":"COMPLETED","sponsor":"Verona Pharma plc","startDate":"2024-08-16","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":46},{"nctId":"NCT07398287","phase":"PHASE2","title":"Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease","status":"NOT_YET_RECRUITING","sponsor":"Region Skane","startDate":"2026-02-15","conditions":"Interstitial Lung Disease (ILD)","enrollment":20},{"nctId":"NCT07394036","phase":"PHASE2","title":"Effect of Ipratropium Bromide on EILO","status":"NOT_YET_RECRUITING","sponsor":"Cook Children's Health Care System","startDate":"2026-03-16","conditions":"Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity","enrollment":50},{"nctId":"NCT03257319","phase":"PHASE3","title":"Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department","status":"COMPLETED","sponsor":"University Hospital, Rouen","startDate":"2017-09-19","conditions":"Pain, Acute, Emergencies, Morphine","enrollment":226},{"nctId":"NCT06622291","phase":"PHASE4","title":"Perioperative Nitric Oxide Prevents Acute Kidney Injury in Acute Type A Aortic Dissection Patients","status":"COMPLETED","sponsor":"Beijing Anzhen Hospital","startDate":"2024-11-30","conditions":"Acute Kidney Injury, Nitrous Oxide, Acute Type A Aortic Dissection","enrollment":106},{"nctId":"NCT07223294","phase":"PHASE3","title":"Study to Evaluate the Therapeutic Equivalence and Safety of Fluticasone Furoate and Vilanterol Inhalation Powder 100 mcg/25 mcg and BREO ELLIPTA 100 mcg/25 mcg in Participants With Asthma","status":"NOT_YET_RECRUITING","sponsor":"Sandoz","startDate":"2026-04","conditions":"Respiratory","enrollment":1430},{"nctId":"NCT07387315","phase":"PHASE4","title":"A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections","status":"NOT_YET_RECRUITING","sponsor":"TriHealth Inc.","startDate":"2026-02","conditions":"Overactive Bladder, Neurogenic Bladder, Urge Incontinence","enrollment":96},{"nctId":"NCT06624696","phase":"PHASE4","title":"Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia","status":"RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2024-11-12","conditions":"Respiratory Hypersensitivity, Perioperative Respiratory Adverse Events, Anticholinergics","enrollment":204},{"nctId":"NCT04677569","phase":"PHASE3","title":"Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex","status":"COMPLETED","sponsor":"Insmed Incorporated","startDate":"2021-04-01","conditions":"Mycobacterium Infections, Nontuberculous","enrollment":425},{"nctId":"NCT04157348","phase":"PHASE3","title":"Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-10-29","conditions":"Eosinophilic Granulomatous Vasculitis","enrollment":140},{"nctId":"NCT04636814","phase":"PHASE3","title":"A 52-week, Placebo- and Active- Controlled (Roflumilast, Daliresp® 500µg) Study to Evaluate the Efficacy and Safety of Two Doses of CHF6001 DPI (Tanimilast) as add-on to Maintenance Triple Therapy in Subjects With COPD and Chronic Bronchitis. (PILLAR)","status":"TERMINATED","sponsor":"Chiesi Farmaceutici S.p.A.","startDate":"2021-07-12","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":3973},{"nctId":"NCT01478152","phase":"NA","title":"Effect of Ectoin® Inhalation Solution on Subjects With Mild Bronchial Asthma","status":"COMPLETED","sponsor":"Bitop AG","startDate":"2009-08","conditions":"Asthma","enrollment":18},{"nctId":"NCT07367594","phase":"NA","title":"Lavender vs Bitter Orange Aromatherapy to Reduce Anxiety and Pain in Pediatric Local Anesthesia","status":"NOT_YET_RECRUITING","sponsor":"October University for Modern Sciences and Arts","startDate":"2026-02","conditions":"Dental Anxiety, Local Anesthesia","enrollment":26},{"nctId":"NCT04481555","phase":"PHASE4","title":"Eosinophil-guided Reduction of Inhaled Corticosteroids","status":"COMPLETED","sponsor":"Chronic Obstructive Pulmonary Disease Trial Network, Denmark","startDate":"2021-06-28","conditions":"COPD, Inhaled Corticosteroid, Azithromycin","enrollment":444},{"nctId":"NCT07180602","phase":"NA","title":"Healing Minds II: Biofeedback, Breathing Practices, Nutrition and Exercise Counseling in Children and Adolescents With ADHD","status":"WITHDRAWN","sponsor":"Hoskinson Health and Wellness Clinic","startDate":"2025-09","conditions":"Attention Deficit Disorder With Hyperactivity (ADHD)","enrollment":""},{"nctId":"NCT07369973","phase":"NA","title":"Respiratory Biofeedback Added to Strengthening Training in Patients With Chronic Kidney Disease","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-01","conditions":"Chronic Kidney Disease (Stages 4 and 5)","enrollment":24},{"nctId":"NCT07369232","phase":"NA","title":"Cerebral Hemodynamic Effects of Oxygen and Antioxidants (CHEOXANT)","status":"RECRUITING","sponsor":"Erasme University Hospital","startDate":"2025-09-01","conditions":"Oxygen, Hyperoxemia, Antioxidant","enrollment":10},{"nctId":"NCT07368374","phase":"NA","title":"EFFECTS OF CİTRUS AND CLOVE OİL AROMATHERAPY İN OLDER ADULTS","status":"NOT_YET_RECRUITING","sponsor":"Mersin University","startDate":"2026-02-01","conditions":"Aromatherapy","enrollment":51},{"nctId":"NCT07364643","phase":"NA","title":"Effectiveness of an Educational Intervention on Asthmatic Children in Inhaled Technique and Adherence.","status":"NOT_YET_RECRUITING","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2026-01","conditions":"Asthma Childhood","enrollment":428},{"nctId":"NCT05943535","phase":"PHASE3","title":"Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)","status":"RECRUITING","sponsor":"United Therapeutics","startDate":"2023-10-30","conditions":"Progressive Pulmonary Fibrosis, Interstitial Lung Disease","enrollment":698},{"nctId":"NCT07352488","phase":"NA","title":"Modified Shenling Baizhu Powder for Allergic Asthma With Spleen Deficiency and Dampness Accumulation Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Henan University of Traditional Chinese Medicine","startDate":"2026-01-15","conditions":"Allergic Asthma","enrollment":400},{"nctId":"NCT06237335","phase":"PHASE2","title":"A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF","status":"RECRUITING","sponsor":"ReCode Therapeutics","startDate":"2024-02-01","conditions":"Cystic Fibrosis","enrollment":192},{"nctId":"NCT07344558","phase":"PHASE1","title":"A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Mannkind Corporation","startDate":"2025-12-22","conditions":"Idiopathic Pulmonary Fibrosis (IPF)","enrollment":24},{"nctId":"NCT05357040","phase":"PHASE2","title":"Antidepressant Effects of Nitrous Oxide","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-06-30","conditions":"Major Depressive Disorder, Treatment Resistant Depression","enrollment":172},{"nctId":"NCT05357066","phase":"PHASE2","title":"Nitrous Oxide as Treatment for Fibromyalgia","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-11-12","conditions":"Fibromyalgia, Central Neuropathic Pain","enrollment":50},{"nctId":"NCT03696290","phase":"PHASE4","title":"Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis","status":"TERMINATED","sponsor":"University of Dundee","startDate":"2019-10-19","conditions":"Bronchiectasis Adult","enrollment":34},{"nctId":"NCT07317050","phase":"PHASE3","title":"Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment","status":"NOT_YET_RECRUITING","sponsor":"Fundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion","startDate":"2026-03-01","conditions":"Acute Respiratory Distress Syndrome (ARDS)","enrollment":156},{"nctId":"NCT07329049","phase":"NA","title":"The Effect of Inspiratory Muscle Training on Cognitive Functions, Cerebral Oxygenation, and Neurotrophic Factor Level in Patients With Obstructive Sleep Apnea Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Istinye University","startDate":"2026-01","conditions":"Obstructive Sleep Apnea Syndrome (OSAS)","enrollment":42},{"nctId":"NCT07326995","phase":"PHASE2","title":"Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma","status":"RECRUITING","sponsor":"Anhui Palo Alto Pharmaceuticals, Inc.","startDate":"2025-02-24","conditions":"Bronchial Asthma","enrollment":60},{"nctId":"NCT04783155","phase":"NA","title":"Effect of Inspiratory Muscle Training on Physiological Function and Clinical Outcomes After Lung Transplant","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-05-10","conditions":"Post-Lung Transplantation Bronchiectasis","enrollment":30},{"nctId":"NCT07172984","phase":"NA","title":"The Value of Standardized Respiratory Rate Monitoring Exercises During Rheumatological Injection Procedures","status":"RECRUITING","sponsor":"Centre Hospitalier Metropole Savoie","startDate":"2025-09-19","conditions":"Rheumatological Injection, Pain Management, Respiratory Monitoring","enrollment":136},{"nctId":"NCT06429930","phase":"PHASE1","title":"Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults","status":"RECRUITING","sponsor":"Pharmosa Biopharm Inc.","startDate":"2025-04-11","conditions":"Pulmonary Arterial Hypertension","enrollment":32},{"nctId":"NCT07305493","phase":"NA","title":"Lavender (Lavandula Angustifolia) Aromatherapy Inhalation as an Anti-Anxiety Treatment for Pain","status":"COMPLETED","sponsor":"Universitas Islam Indonesia","startDate":"2022-10-01","conditions":"Anxiety, Pain, Aromatherapy","enrollment":68},{"nctId":"NCT06999603","phase":"PHASE2","title":"Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection","status":"RECRUITING","sponsor":"Synairgen Research Ltd.","startDate":"2025-09-02","conditions":"Viral Pneumonia","enrollment":550},{"nctId":"NCT06916273","phase":"PHASE1","title":"Safety, Tolerability, and Pharmacokinetics of PA9159 Inhalation Aerosol in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Anhui Palo Alto Pharmaceuticals, Inc.","startDate":"2024-07-22","conditions":"Bronchial Asthma","enrollment":40},{"nctId":"NCT05173818","phase":"PHASE2","title":"Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms","status":"COMPLETED","sponsor":"Essentia Health","startDate":"2022-06-28","conditions":"Persistent Post-concussive Syndrome, Concussion Post Syndrome","enrollment":20},{"nctId":"NCT07301203","phase":"PHASE1","title":"Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects","status":"RECRUITING","sponsor":"Beijing Tide Pharmaceutical Co., Ltd","startDate":"2025-10-21","conditions":"Healthy, Healthy Participants","enrollment":90},{"nctId":"NCT05742243","phase":"PHASE2","title":"Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"Melbourne Health","startDate":"2023-02-13","conditions":"Type 1 Diabetes, Diabetes Mellitus, Type 1","enrollment":68},{"nctId":"NCT06035393","phase":"PHASE2","title":"A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease","status":"TERMINATED","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-01-15","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":82},{"nctId":"NCT05320367","phase":"PHASE1, PHASE2","title":"A Study of Inhaled Cannabidiol in Healthy Occasional Cannabis Users","status":"NOT_YET_RECRUITING","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2026-09","conditions":"Cannabis","enrollment":80},{"nctId":"NCT03736538","phase":"PHASE1","title":"Nitrous Oxide- Suicidal Ideation","status":"ENROLLING_BY_INVITATION","sponsor":"Washington University School of Medicine","startDate":"2018-10-30","conditions":"Major Depressive Disorder, Depression, Mood Disorders","enrollment":50},{"nctId":"NCT07209501","phase":"NA","title":"Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT)","status":"ENROLLING_BY_INVITATION","sponsor":"Singapore General Hospital","startDate":"2025-05-15","conditions":"Chemotherapy-Induced Nausea and Vomiting (CINV)","enrollment":30},{"nctId":"NCT06070233","phase":"NA","title":"Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2023-10-12","conditions":"Spasticity as Sequela of Stroke, Spastic Cerebral Palsy, Spasticity, Muscle","enrollment":22},{"nctId":"NCT06785272","phase":"PHASE3","title":"Magnesium Trial in Acute Asthma in Emergency Department","status":"RECRUITING","sponsor":"Suzanne Schuh","startDate":"2025-10-08","conditions":"Asthma","enrollment":192},{"nctId":"NCT05309551","phase":"NA","title":"Inspiratory Muscle Training Immediately After Lung Transplantation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2022-04-20","conditions":"Lung Transplantation, Chronic Lung Disease, Muscle Weakness","enrollment":90},{"nctId":"NCT04375514","phase":"PHASE1, PHASE2","title":"Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2020-07-30","conditions":"Cystic Fibrosis, Pulmonary","enrollment":43},{"nctId":"NCT07285655","phase":"PHASE3","title":"A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD","status":"NOT_YET_RECRUITING","sponsor":"Liquidia Technologies, Inc.","startDate":"2026-04","conditions":"Pulmonary Hypertension Due to Lung Disease (Disorder)","enrollment":344}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo for Inhalation","genericName":"Placebo for Inhalation","companyName":"CanSino Biologics Inc.","companyId":"cansino-biologics-inc","modality":"Biologic","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}